Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AdaptHealth (AHCO) EBITDA Margin (2019 - 2025)

AdaptHealth has reported EBITDA Margin over the past 7 years, most recently at 2.27% for Q4 2025.

  • Quarterly results put EBITDA Margin at 2.27% for Q4 2025, down 1905.0% from a year ago — trailing twelve months through Dec 2025 was 13.94% (down 467.0% YoY), and the annual figure for FY2025 was 13.94%, down 466.0%.
  • EBITDA Margin for Q4 2025 was 2.27% at AdaptHealth, down from 18.81% in the prior quarter.
  • Over the last five years, EBITDA Margin for AHCO hit a ceiling of 21.32% in Q4 2024 and a floor of 46.11% in Q3 2023.
  • Median EBITDA Margin over the past 5 years was 17.53% (2022), compared with a mean of 11.95%.
  • Biggest five-year swings in EBITDA Margin: tumbled -6400bps in 2023 and later soared 6456bps in 2024.
  • AdaptHealth's EBITDA Margin stood at 19.1% in 2021, then decreased by -20bps to 15.25% in 2022, then crashed by -200bps to 15.26% in 2023, then surged by 240bps to 21.32% in 2024, then tumbled by -89bps to 2.27% in 2025.
  • The last three reported values for EBITDA Margin were 2.27% (Q4 2025), 18.81% (Q3 2025), and 20.8% (Q2 2025) per Business Quant data.